Role of Low Dose Overnight Dexamethasone Supression Test (Lodst) in Management Protocol for Cushing’s Syndrome

Introduction: Overnight low dose The Dexamethasone Supression Test (LODST) is a diagnostic method for Cushing’s syndrome that occurs spontaneously (CS). A negative LODST law rules out CS. However, there are two exceptions: monitoring during the silent phase of Cyclic Cushing’s disease (CD) or a false negative caused by one mg dexamethasone in early or moderate…
Read more

March 17, 2021 0